TOP HEADLINES

Featured Story

Clinverse reels in a $9.1M funding round to expand its trial tech

Durham, NC's Clinverse has put together a $9.1 million C round, raising cash to support its technology for managing costs in clinical trials.

CRO PharPoint signs up to get Otologic's hearing drug into the clinic

Biotech Otologic Pharmaceuticals has chosen North Carolina's PharPoint Research to run an early trial of its lead candidate, a treatment for hearing loss.

Quintiles and Illumina look to jump-start cancer R&D with genomics sweepstakes

Global CRO Quintiles and gene sequencing magnate Illumina are scouting for some promising scientists, offering the use of their cash and technology to advance oncology research.

Recipharm buys into Italy with $165M CMO deal

Swedish contract developer Recipharm is looking to expand its share of the European manufacturing market, trading $164.5 million for Italy's Corvette Pharmaceutical Services.

WuXi's manufacturing boom spells a big quarter

WuXi PharmaTech, China's largest CRO, boosted its revenue by 14.8% in the second quarter, as banner growth in its contract manufacturing business helped the company expand its global reach.

MORE NEWS

From Our Sister Sites

FierceBiotech

Late on Monday evening Exelixis put out the word that its crucial late-stage study of cabozantinib flunked a comparison study with prednisone for castration-resistant prostate cancer, triggering a restructuring that will eliminate 70% of the jobs at the biotech.

FierceBiotechIT

Amazon is the latest tech giant to consider expanding into healthcare, but details of the online retailer's plans are sketchy.